Mobile menu icon
Mobile menu icon Search iconSearch
Search type


Biomarkers research at Manchester is driven by outstanding researchers who work together to turn our discoveries into real-world solutions to healthcare challenges.

The Stoller Biomarker Discovery Centre carries out research to identify biomarkers – the molecular clues to the presence of a disease.

The Manchester Molecular Pathology Innovation Centre (MMPathIC) translates biomarkers into clinically usable tests that could improve and speed up the process of diagnosing, predicting and identifying the best treatment for diseases in question.

Both of these centres operate under the umbrella of the Manchester Precision Medicine Institute and work with other groups including the Manchester Cancer Research Centre and the Cancer Research UK Manchester Institute.